Steven M. Bromidge

Covalent targeted radioligands potentiate radionuclide therapy

Psychedelics reopen the social reward learning critical period

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

Design of [R-(Z)]-(+)-α-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a Functionally Selective Azabicyclic Muscarinic M1 Agonist Incorporating the N-Methoxy Imidoyl Nitrile Group as a Novel Ester Bioisostere